CLSI C52-2017

$48.10

Toxicology and Drug Testing in the Medical Laboratory

Published By	Publication Date	Number of Pages
CLSI	2017-01-01	58

Guaranteed Safe Checkout

Category: CLSI

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

Description

Clinical and Laboratory Standards Institute guideline C52—Toxicology and Drug Testing in the Medical Laboratory helps medical laboratories develop procedures for analyzing drugs of abuse and other compounds. C52 provides guidance on clinical toxicology testing from the initial consultation through final result reporting and interpretation, and includes a variety of specimen types, analytical procedures, and instrumentation.

This guideline discusses the most common purposes for clinical toxicology testing, including the support of emergency medicine, obstetrics and gynecology, neonatology, pediatrics, psychiatry, pain management, and addiction medicine. The primary objective is to ensure high-quality standards are maintained throughout the entire testing process, from specimen collection, processing, and analysis, through results reporting and interpretation.

Additional information

Published Code	CLSI
Published By	Clinical and Laboratory Standards Institute
Publication Date	2017-01-01
Pages Count	58
Language	English
Descriptors	Abused drugs, clinical toxicology. controlled substances, drug abuse, drug screen, drug testing, drugs, drugsof abuse, emergency toxicology, ethanol, forensic toxicology, intoxication, overdose, serum drug testing,substance abuse, therapeutic drugs, toxicology. urine drug testing
Edition	3
File Size	2.2 MB
ISBN	1562388088

Preview PDF


PDF Format	Searchable	Printable	Preview Now

CLSI C52-2017

Related products